We are live on
!
Find out more
C WorldWide Group Portfolio holdings
AUM
$4.15B
Turnover
9.8%
1-Year Est. Return
13.14%
This Fund
S&P 500
This Quarter
Est. Return
+5.63%
1 Year Est. Return
+13.14%
3 Year Est. Return
+63.19%
5 Year Est. Return
+70.18%
10 Year Est. Return
+417.82%
AUM
$5.73B
AUM Growth
-$759M
(-12%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-17.7%
Top 10 Holdings %
Top 10 Hldgs %
59.74%
Holding
102
New
7
Increased
11
Reduced
53
Closed
5
Avg Time Held
4.3
years
Top 10 Avg Time Held
5.1
years
Top 20 Avg Time Held
5.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mercado Libre
MELI
|
+$94M |
| 2 |
LENZ Therapeutics
LENZ
|
+$14.6M |
| 3 |
BJs Wholesale Club
BJ
|
+$9.11M |
| 4 |
Procept Biorobotics
PRCT
|
+$7.46M |
| 5 |
Royal Gold
RGLD
|
+$5.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$159M |
| 2 |
Ferguson
FERG
|
+$96.9M |
| 3 |
Microsoft
MSFT
|
+$85.6M |
| 4 |
Amazon
AMZN
|
+$81.1M |
| 5 |
Linde
LIN
|
+$75.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.82% |
| 2 | Healthcare | 17.52% |
| 3 | Technology | 14.79% |
| 4 | Consumer Discretionary | 11.05% |
| 5 | Communication Services | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Ionis Pharmaceuticals
IONS
$7.14B
| $29M | 0.51% |
366,000
-60,000
| -14% | -$4.52M |
2023 Q4
8 quarters
|
|
27
Royalty Pharma
RPRX
$27.1B
| $27.1M | 0.47% |
700,461
+46,004
| +7% | +$1.75M |
2025 Q1
3 quarters
|
|
28
Meta Platforms (Facebook)
META
$1.8T
| $25.3M | 0.44% |
38,344
+4,834
| +14% | +$3.23M |
2025 Q3
1 quarter
|
|
29
Sea Limited
SE
$57.8B
| $25.2M | 0.44% |
197,648
-38,777
| -16% | -$5.74M |
2020 Q1
23 quarters
|
|
|
30
Ferguson
FERG
$44.6B
| $24.5M | 0.43% |
129,762
-405,601
| -76% | -$96.9M |
2022 Q3
13 quarters
|
|
31
Medtronic
MDT
$121B
| $24.5M | 0.43% |
255,000
| – | – |
2023 Q4
8 quarters
|
|
32
Insulet
PODD
$9.8B
| $24.1M | 0.42% |
84,908
-10,000
| -11% | -$3.13M |
2014 Q3
45 quarters
|
|
33
Insmed
INSM
$21.1B
| $23.7M | 0.41% |
136,110
-60,000
| -31% | -$10.9M |
2017 Q1
35 quarters
|
|
34
Glaukos
GKOS
$9.66B
| $23.4M | 0.41% |
207,212
| – | – |
2016 Q2
38 quarters
|
|
35
Elevance Health
ELV
$93.2B
| $22.8M | 0.4% |
65,000
-23,000
| -26% | -$7.77M |
2017 Q3
33 quarters
|
|
36
Penumbra
PEN
$12.6B
| $22.4M | 0.39% |
72,000
| – | – |
2024 Q1
7 quarters
|
|
37
Krystal Biotech
KRYS
$9.39B
| $21.2M | 0.37% |
85,809
| – | – |
2020 Q1
23 quarters
|
|
38
Vertex Pharmaceuticals
VRTX
$126B
| $20.9M | 0.36% |
46,057
| – | – |
2014 Q3
45 quarters
|
|
39
Service Corp International
SCI
$11.1B
| $19.2M | 0.34% |
246,428
-11,566
| -4% | -$925K |
2019 Q4
24 quarters
|
|
40
Neurocrine Biosciences
NBIX
$13.8B
| $17.7M | 0.31% |
125,000
| – | – |
2024 Q2
6 quarters
|
|
41
Synopsys
SNPS
$86.5B
| $17.6M | 0.31% |
37,419
+3,555
| +10% | +$1.58M |
2020 Q3
21 quarters
|
|
42
Tencent Music
TME
$14.1B
| $16.5M | 0.29% |
941,058
-162,085
| -15% | -$3.29M |
2024 Q2
6 quarters
|
|
43
BioMarin Pharmaceuticals
BMRN
$10.6B
| $15.9M | 0.28% |
267,851
+30,000
| +13% | +$1.63M |
2014 Q3
45 quarters
|
|
44
Hesai Group
HSAI
$1.96B
| $15.6M | 0.27% |
697,133
-117,984
| -14% | -$2.58M |
2025 Q3
1 quarter
|
|
45
PTC
PTC
$21B
| $14.7M | 0.26% |
84,122
-1,211
| -1% | -$225K |
2020 Q3
21 quarters
|
|
46
Privia Health
PRVA
$2.89B
| $14.5M | 0.25% |
610,000
| – | – |
2022 Q2
14 quarters
|
|
47
iRhythm Holdings
IRTC
$3.63B
| $14.2M | 0.25% |
80,000
| – | – |
2020 Q4
20 quarters
|
|
48
MSCI
MSCI
$41.2B
| $13.9M | 0.24% |
24,244
-347
| -1% | -$195K |
2019 Q2
26 quarters
|
|
49
Waters Corp
WAT
$42.6B
| $13.9M | 0.24% |
36,493
-525
| -1% | -$193K |
2020 Q3
21 quarters
|
|
50
ResMed
RMD
$33.5B
| $13.5M | 0.24% |
56,020
-801
| -1% | -$205K |
2020 Q3
21 quarters
|
|
Similar funds
C WorldWide Group's Q4 2025 Portfolio in Review
As of Q4 2025, C WorldWide Group held 102 positions worth $5.73B, down 12% from $6.49B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
C WorldWide Group withdrew a net $1.01B in Q4 2025, closing 5 positions and reducing 53 holdings. Its most notable exit was Electronic Arts, an estimated $15.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
Against the trend, C WorldWide Group opened a new position in LENZ Therapeutics worth $8M.
- C WorldWide Group's largest Q4 2025 buy was LENZ Therapeutics: 500,000 shares worth $8M.
- C WorldWide Group added most to Mercado Libre in Q4 2025, an estimated $94M increase.
- C WorldWide Group's biggest Q4 2025 reduction was Alphabet (Google) Class C, cutting an estimated $159M.
- C WorldWide Group fully exited Electronic Arts in Q4 2025, selling an estimated $15.1M.
- C WorldWide Group's ten largest holdings make up 60% of its $5.73B portfolio in Q4 2025.
- C WorldWide Group opened 7 new positions and closed 5 in Q4 2025.
- C WorldWide Group's portfolio value fell 12% quarter-over-quarter to $5.73B.
Based on C WorldWide Group's 13F filing for Q4 2025, filed 4 Feb 2026.